Labeling human embryonic stem cell-derived cardiomyocytes with indocyanine green for noninvasive tracking with optical imaging: an FDA-compatible alternative to firefly luciferase.

@article{Boddington2010LabelingHE,
  title={Labeling human embryonic stem cell-derived cardiomyocytes with indocyanine green for noninvasive tracking with optical imaging: an FDA-compatible alternative to firefly luciferase.},
  author={Sophie E. Boddington and Tobias D. Henning and Priyanka Jha and Christopher R. Schlieve and Lydia G. Mandrussow and David G DeNardo and Harold S Bernstein and Carissa Ritner and Daniel Golovko and Ying Lu and Shoujun Zhao and Heike E. Daldrup-Link},
  journal={Cell Transplantation},
  year={2010},
  volume={19},
  pages={55-65}
}
Human embryonic stem cell-derived cardiomyocytes (hESC-CMs) have demonstrated the ability to improve myocardial function following transplantation into an ischemic heart; however, the functional benefits are transient possibly due to poor cell retention. A diagnostic technique that could visualize transplanted hESC-CMs could help to optimize stem cell delivery techniques. Thus, the purpose of this study was to develop a labeling technique for hESCs and hESC-CMs with the FDA-approved contrast… CONTINUE READING

Similar Papers

Citations

Publications citing this paper.
SHOWING 1-10 OF 15 CITATIONS